PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+33.39%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.75B
AUM Growth
+$1.75B
(+25%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
6.45%
Top 10 Holdings %
Top 10 Hldgs %
46.67%
Holding
235
New
45
Increased
31
Reduced
38
Closed
62
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$50.5M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$26.9M |
| 3 |
Evolent Health
EVH
|
$25.3M |
| 4 |
RDUS
Radius Health, Inc.
RDUS
|
$25M |
| 5 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$24.5M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$68.8M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$39.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
$29.6M |
| 4 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$23.3M |
| 5 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$13.5M |
Sector Composition
| 1 | Healthcare | 93.5% |
| 2 | Consumer Discretionary | 0.07% |
| 3 | Industrials | 0.03% |
| 4 | Technology | 0.03% |
| 5 | Energy | 0.01% |
